Home
Chemicals

Sector: Chemicals

Report urges companies to hunt for more value from their patents

PatSnap’s “State of IP” report reveals intelligence about patent value, monetisation strategies, IP department budgets and more

Nanoco eyeing further assertions following big-money Samsung pay-out, says CEO

Brian Tenner sits down with IAM to discuss the company’s win and future strategy

The fast-evolving cannabis patent dispute landscape

GW’s recent ANDA lawsuit is a landmark moment, but will remain untypical of cannabis IP litigation

Latest content

China’s top 100 patent filers: positions 1 to 33

Featured in Special Report 2021 Q1: On the shoulders of giants

25 March 2021

Staunch critic of Big Pharma IP strategies confirmed as US Health Secretary

Xavier Becerra may push for anti-patentee policies at HHS, but much remains unknown about the Biden administration’s approach

23 March 2021

EU Teva investigation shows IP’s competition law issues aren’t limited to patent litigation settlements

Commission’s move against the Israeli generic is unprecedented, but could be a sign of things to come

18 March 2021

Drop in foreign filings drives Taiwan patent numbers lower

But key players in the chip sector, both foreign and domestic, increased their output in a year that saw huge electronics demand

15 March 2021

Covid-19 patent landscape confusion is a big concern for life sciences organisations

Providing new insights into recent filings, but patent landscape uncertainties may pose dangers in the wake of the pandemic

09 March 2021

Samsung, LG and South Korea’s trade secrets dilemma

The long read: Few countries are more focused on the threat of IP leaks to China than South Korea. But when it comes to shoring up legal protections for trade secrets, senior leaders have put on the brakes, anticipating threats to key industry players and national technology goals

03 March 2021

Unlock unlimited access to all IAM content